| Literature DB >> 35415623 |
Yihui Gong1, Jun Song2, Leslie Campbell Palmer2, Mindy Vinqvist-Tymchuk2, Sherry Fillmore2, Peter Toivonen3, ZhaoQi Zhang1.
Abstract
Superficial scald is a physiological storage disorder that significantly reduces the marketability of apple fruit. To gain fundamental knowledge about the biochemical pathways leading to the development of the disorder and mechanisms of treatments for prevention, an untargeted metabolomics experiment employing liquid chromatography and mass spectrometry with data independent acquisition was performed. Metabolomic changes of two apple cultivars 'Cortland' and 'Red Delicious' with scald development and scald control treatments, using diphenylamine and 1-MCP, at 0-1 °C for up to 7 months was investigated. In total, 833 features/compounds were analyzed, and among them 59 were found to change significantly in controls involved in scald development, and in response to DPA and 1-MCP treatments. Our results provide new evidence that metabolites in association with phenylpropanoid metabolism, antioxidant and redox systems, and amino acid metabolism are related closely to scald development and response to potential treatments.Entities:
Keywords: Data independent acquisition; Malus domestica; Mass spectrometry; Metabolomics; Superficial scald
Year: 2021 PMID: 35415623 PMCID: PMC8991853 DOI: 10.1016/j.fochms.2021.100022
Source DB: PubMed Journal: Food Chem (Oxf) ISSN: 2666-5662
Significantly changed phenolic compounds putatively identified in ‘Cortland’ and ‘Red delicious’ during 7 months storage and in response to DPA and 1-MCP treatments employing untargeted qTOF LC/MS.
| Peak No. | Compounds Rt_ | Adducts | Formula | Score | Mass Error (ppm) | Description | |||
|---|---|---|---|---|---|---|---|---|---|
| 1 | 2.23_295.0663 | M + Na-2H | C9H14N4O6 | 47.6 | 1.22 | N4-carboxy-1-(beta- | 0.001 | ns | <0.001 |
| 2 | 2.67_329.0871 | M−H | C14H18O9 | 44.7 | −2.28 | 1-O-vanilloyl-beta- | 0.007 | ns | 0.002 |
| 3 | 3.00_467.1192 | M + Na-2H | C19H26O12 | 53.1 | 4.69 | gaultherin | 0.017 | 0.008 | ns |
| 4 | 3.03_137.0235 | M−H | C5H4N3O2- | 53.4 | −0.54 | 2-amino-4-pyrimidinecarboxylate | 0.004 | ns | 0.002 |
| 5 | 3.03_299.0765 | M−H | C13H16O8 | 42.3 | −2.47 | 4-hydroxybenzoyl glucose | 0.002 | ns | <0.001 |
| 6 | 3.29_575.1190 | M−H2O−H | C30H26O13 | 49.9 | −0.74 | (+)-gallocatechin-(4alpha->8)-(−)-epicatechin | 0.014 | 0.004 | ns |
| 7 | 3.54_368.0978 | M−H | C16H19NO9 | 39.0 | −2.43 | [3-(hexopyranosyloxy)-2-oxo-2,3-dihydro-1 | 0.009 | ns | 0.002 |
| 8 | 3.58_329.0870 | M−H | C14H18O9 | 43.0 | −2.47 | vanillic Acid 4-β- | <0.001 | ns | <0.001 |
| 9 | 3.58_167.0341 | M−H2O−H | C8H10O5 | 46.3 | −4.84 | 2-hydroxy-2-(2-methylenecyclopropyl)succinic acid | <0.001 | 0.049 | <0.001 |
| 10 | 3.65_162.0520n | M−H2O−H, M−H | C6H10O5 | 47.0 | −4.98 | 0.004 | 0.031 | 0.009 | |
| 11 | 3.66_220.0606 | M−H | C11H11NO4 | 43.6 | −4.21 | 2,2-dimethyl-5-(2(1 | <0.001 | <0.001 | <0.001 |
| 12 | 3.99_299.0765 | M−H | C13H16O8 | 47.1 | −2.56 | 1-O-(2-Hydroxybenzoyl)-beta- | 0.002 | 0.001 | 0.092 |
| 13 | 4.16_451.1237 | M−H | C21H24O11 | 45.4 | −2.01 | aspalathin | 0.008 | ns | 0.006 |
| 14 | 4.26_449.1084 | M−H | C21H22O11 | 43.9 | −1.21 | dihydroquercetin 3-rhamnoside | 0.009 | 0.004 | ns |
| 15 | 4.50_577.1417 | M−H | C30H26O12 | 52.5 | −1.21 | ns | ns | ns | |
| 16 | 4.61_481.1344 | M + Na-2H | C20H28O12 | 44.1 | 3.57 | paeonolide | 0.045 | 0.015 | ns |
| 17 | 4.73_355.1024 | M−H | C16H20O9 | 40.5 | −2.96 | 1-O-feruloyl-beta- | <0.001 | ns | <0.001 |
| 18 | 4.75_466.1108n | M−H2O−H, M−H, M + Na-2H | C21H22O12 | 54.0 | −0.64 | plantagoside | 0.005 | 0.001 | ns |
| 19 | 4.91_327.1077 | M−H2O−H | C15H22O9 | 43.8 | −2.29 | deutzioside | 0.062 | ns | 0.020 |
| 20 | 4.99_307.1026 | M−H2O−H | C12H22O10 | 47.4 | −2.68 | neohesperidose | <0.001 | <0.001 | <0.001 |
| 21 | 5.15_354.0942n | M−H, M + Na-2H | C16H18O9 | 46.7 | −2.42 | ns | ns | ns | |
| 22 | 5.16_245.0811 | M−H | C14H14O4 | 42.6 | −3.48 | benzyl 1-hydroxy-6-oxo-2-cyclohexene-1-carboxylate | 0.058 | ns | 0.031 |
| 23 | 5.16_289.0710 | M−H | C15H14O6 | 41.4 | −2.63 | ns | ns | 0.048 | |
| 24 | 5.41_465.1033 | M−H | C21H22O12 | 46.8 | −1.09 | epi-catechin-3′-glucoronide | <0.001 | <0.001 | ns |
| 25 | 5.44_865.1977 | M−H | C45H38O18 | 52.6 | −0.98 | arecatannin B1 | 0.023 | ns | 0.011 |
| 26 | 5.51_578.1418n | M−H, M + Na-2H | C30H26O12 | 53.5 | −1.05 | 0.002 | ns | <0.001 | |
| 27 | 5.58_263.1128 | M + Na-2H | C10H18N4O3 | 39.4 | 1.08 | N′-[(2Z,3E)-3-(Hydroxyimino)-2-butanylidene]-2-(4-morpholinyl)acetohydrazide | 0.015 | 0.040 | 0.034 |
| 28 | 5.67_436.0999n | M−H2O−H, M−H | C20H20O11 | 39.8 | −1.60 | Swertianolin | <0.001 | <0.001 | ns |
| 29 | 5.74_425.1658 | M + Na-2H | C16H28N4O8 | 40.9 | 0.94 | 1,4,13,16-tetraoxa-7,10,19,22-tetraazacyclotetracosane-6,9,20,23-tetrone | 0.018 | 0.027 | 0.066 |
| 30 | 5.77_193.0497 | M−H2O−H | C10H12O5 | 52.7 | −4.17 | 3,5-dimeoxy-4-dimethoxy-4-hydroxyphenylacetic acid | 0.046 | ns | 0.014 |
| 31 | 5.77_355.1026 | M−H2O−H | C16H20O9 | 49.2 | −2.43 | gardoside | 0.021 | ns | 0.006 |
| 32 | 5.94_320.0525n | M−H2O−H M−H | C15H12O8 | 41.0 | −2.33 | (2R)-2-(3,4-Dihydroxyphenyl)-3,5,7,8-tetrahydroxy-2,3-dihydro-4 | 0.002 | <0.001 | ns |
| 33 | 5.96_179.0345 | M−H | C9H8O4 | 41.2 | −2.76 | ns | ns | ns | |
| 34 | 5.96_245.0811 | M−H | C14H14O4 | 47.4 | −3.54 | marmesin | 0.024 | ns | 0.020 |
| 35 | 5.96_290.0783n | M−H, M + Na-2H | C15H14O6 | 42.0 | −2.59 | 0.020 | 0.068 | 0.029 | |
| 36 | 5.96_579.1502 | M−H | C30H28O12 | 52.9 | −1.12 | 5,7-dihydroxy-2-(4-hydroxy-2,5-cyclohexadien-1-ylidene)-2 | 0.040 | 0.057 | 0.085 |
| 37 | 6.08_381.1758 | M−H | C16H30O10 | 42.2 | −2.12 | dimethyl 3,6,9,12,15,18-hexaoxaicosane-1,20-dioate | 0.007 | ns | 0.002 |
| 38 | 6.13_866.2057n | M−H, M + Na-2H | C45H38O18 | 50.1 | −0.18 | 0.024 | ns | 0.010 | |
| 39 | 6.16_173.0446 | M−H2O−H | C7H12O6 | 45.2 | −4.99 | quinic acid | 0.033 | ns | 0.010 |
| 40 | 6.16_337.0921 | M−H | C16H18O8 | 50.8 | −2.23 | 3-O-p-Coumaroylquinic acid | 0.047 | ns | 0.014 |
| 41 | 6.40_381.1758 | M−H | C16H30O10 | 40.6 | −2.12 | dimethyl 3,6,9,12,15,18-hexaoxaicosane-1,20-dioate | 0.010 | ns | 0.004 |
| 42 | 6.57_329.0870 | M−H | C14H18O9 | 39.0 | −2.52 | hydroxytyrosol 3-O-β- | 0.079 | 0.034 | ns |
| 43 | 6.69_395.1915 | M + Na-2H | C16H30N4O6 | 46.2 | 0.78 | glu-val-lys | 0.011 | ns | 0.005 |
| 44 | 6.69_441.1971 | M + Na-2H | C18H28N8O4 | 49.4 | −2.16 | his-his-lys | 0.005 | ns | 0.002 |
| 45 | 6.88_319.0451 | M−H | C15H12O8 | 47.0 | −2.69 | dihydromyricetin | 0.036 | 0.011 | ns |
| 46 | 7.12_609.1458 | M−H | C27H30O16 | 39.6 | −0.56 | <0.001 | <0.001 | <0.001 | |
| 47 | 7.13_189.0760 | M−H | C8H14O5 | 39.5 | −4.23 | 1,4,7,10-Tetraoxacyclododecan-2-one | 0.037 | ns | 0.041 |
| 48 | 7.16_475.1816 | M−H | C21H32O12 | 43.7 | −0.98 | kanokoside A | 0.040 | ns | 0.013 |
| 49 | 7.29_385.1133 | M−H2O−H | C17H24O11 | 40.1 | −1.88 | gardenoside | 0.004 | ns | <0.001 |
| 50 | 7.36_463.0877 | M−H | C21H20O12 | 49.2 | −1.14 | ns | ns | ns | |
| 51 | 7.90_547.2392 | M + Na-2H | C23H42O13 | 41.7 | 3.79 | methyl 2,3,4-tri-O-methyl-beta- | 0.033 | ns | 0.016 |
| 52 | 7.90_623.1614 | M−H | C28H32O16 | 43.2 | −0.58 | isorhamnetin 3-O-rutinoside | <0.001 | 0.078 | <0.001 |
| 53 | 8.02_301.0342 | M−H | C20H18O11 | 51.1 | −4.01 | 0.01 | 0.003 | ns | |
| 54 | 8.09_353.1809 | M + Na-2H | C14H28N4O5 | 41.4 | 0.81 | ser-val-lys | 0.002 | ns | <0.001 |
| 55 | 8.18_289.0710 | M−H | C15H14O6 | 42.1 | −2.63 | (+)-leucopelargonidin | 0.028 | 0.015 | ns |
| 56 | 8.18_452.1307 | M−H | C21H24O11 | 40.5 | −2.67 | 3-hydroxyphloretin 2′-O-glucoside | 0.045 | 0.029 | ns |
| 57 | 8.20_447.0928 | M−H | C21H20O11 | 40.1 | −1.15 | ns | ns | ns | |
| 58 | 8.25_567.1716 | M−H | C26H32O14 | 45.5 | −0.58 | phloretin xylosyl-galactoside | 0.026 | ns | 0.009 |
| 59 | 8.27_477.1035 | M−H | C22H22O12 | 52.7 | −0.72 | isorhamnetin 3-glucoside | 0.003 | ns | 0.001 |
| 60 | 8.41_333.0609 | M−H | C16H14O8 | 46.5 | −2.09 | 2-(3,4-dihydroxy-5-methoxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4 | 0.012 | 0.003 | ns |
| 61 | 8.52_131.0704 | M−H | C4H10N3O2- | 41.1 | −0.97 | 1,1-diethyl-3-oxo-2-triazanolate | <0.001 | <0.001 | ns |
| 62 | 8.82_317.1962 | M−H | C16H30O6 | 39.8 | −2.37 | (+)-neomenthyl beta- | <0.001 | 0.076 | <0.001 |
| 63 | 8.93_373.1284 | M + Na-2H | C18H24O7 | 44.1 | 4.47 | 3-hydroxy-1-(8-hydroxy-6-methoxy-3-methyl-1-oxo-3,4-dihydro-1 | 0.066 | ns | 0.024 |
| 64 | 9.00_435.1291 | M−H | C21H24O10 | 55.3 | −1.17 | ns | ns | ns | |
| 65 | 9.02_167.0341 | M−H2O−H | C8H10O5 | 46.0 | −4.69 | 7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic acid | 0.006 | ns | 0.002 |
| 66 | 9.14_413.1447 | M−H2O−H | C19H28O11 | 41.7 | −1.48 | zizybeoside I | <0.001 | ns | <0.001 |
| 67 | 9.22_566.1631n | M−H, M + Na-2H | C26H30O14 | 42.4 | −0.79 | 3-(5-hydroxy-3,6,7-trimethoxy-4-oxo-4 | <0.001 | <0.001 | 0.002 |
| 68 | 10.58_214.1439 | M−H | C11H21NO3 | 49.7 | −4.32 | propyl N-methyl-N-pentanoylglycinate | 0.023 | 0.015 | ns |
| 69 | 10.83_409.1498 | M + Na-2H | C18H28O9 | 42.1 | 4.55 | 12-hydroxyjasmonic acid glucoside | 0.026 | ns | 0.025 |
* P1 value (Cv × Set × Treat × Store).
**P2 value (PfCv.Set.Ctrl vs D,M.fStore).
***P3 value (DPA vs.1-MCP).
Compounds in bold are confirmed with reference standards.
Fig. 1APCA plot of significantly changed metabolites in ‘Cortland’ and ‘Red Delicious’ apples during storage and in relation to scald development as well as response to DPA and 1-MCP treatments. Data Cort for ‘Cortland’; RDel for ‘Red Delicious’; Ctrl for control, Init for initial at harvest; Feb for at 4 month and May for 7 month storage.
Fig. 1BPCA plot (zoomed from Fig. 1A) of significantly changed metabolites in ‘Cortland’ and ‘Red Delicious’ apples during storage and in relation to scald development as well as response to DPA and 1-MCP treatments. Features were tentatively identified with numbers indicated in Table 1. 2: 1-O-vanilloyl-beta-d-glucose; 4: 2-Amino-4-pyrimidinecarboxylate; 5:1-O-(4-Hydroxybenzoyl)-beta-D-glucopyranose; 8: 2-Hydroxy-2-(2-methylenecyclopropyl)succinic acid; 9: Vanillic Acid 4-β-d-glucopyranoside; 11: 2,2-Dimethyl-5-(2(1H)-pyridinylidene)-1,3-dioxane-4,6-dione; .12: 1-O-(2-Hydroxybenzoyl)-beta-d-glucopyranose; 26: Procyanidin B2; 41: Dimethyl 3,6,9,12,15,18-hexaoxaicosane-1,20-dioate; 43: glu-val-lys; 44: His-his-lys; 46: Rutin; 47: 1,4,7,10-Tetraoxacyclododecan-2-one; 58: Phloretin xylosyl-galactoside; 62: (+)-Neomenthyl beta-d-glucoside. Data Cort for ‘Cortland’; ‘RedDel for Red Delicious’; Init for initial at harvest; Feb for at 4 month and May for 7 month storage.
Fig. 2Significantly changed metabolites during 7 month storage and increased in response to DPA and 1-MCP treatments. Features were tentatively identified and listed in Table 1. A: Gaultherin; B: (+)-gallocatechin-(4alpha->8)-(−)-epicatechin; C: 1-O-(2-Hydroxybenzoyl)-beta-d-glucopyranos; D: Paeonolide; E: Epi-catechin-3′-glucuronide; F: (2R)-2-(3,4-Dihydroxyphenyl)-3,5,7,8-tetrahydroxy-2,3-dihydro-4H-chromen-4-one. Error bars indicate standard error of means.
Fig. 3Significantly changed metabolites during 7 month storage and decreased in response to DPA and 1-MCP treatments. Features were tentatively identified and listed in Table 1. A: Dihydroquercetin 3-rhamnoside; B: Plantagoside; C: Swertianolin; D: 1,4,13,16-Tetraoxa-7,10,19,22-tetraazacyclotetracosane-6,9,20,23-tetrone; E: 5,7-Dihydroxy-2-(4-hydroxy-2,5-cyclohexadien-1-ylidene)-2H-chromen-3-yl6-O-[(2E)-3-(4-hydroxyphenyl)-2-propenoyl]-d-glucopyranoside; F: Dihydromyricetin; G: (+)-Leucopelargonidin; H: 2-(3,4-Dihydroxy-5-methoxyphenyl)-3,5,7-trihydroxy-2,3-dihydro-4H-chromen-4-one; I: 1,1-Diethyl-3-oxo-2-triazanolate. Error bars indicate standard error of means.
Fig. 4Significantly changed metabolites during 7 month storage and in response to DPA and 1-MCP treatments. A: 2-Hydroxy-2-(2-methylenecyclopropyl)succinic acid; B: l-Fucono-1,5-lactone; C: Neohesperidose; D: beta-d-Galactofuranose; E: Rutin; F: 3-(5-Hydroxy-3,6,7-trimethoxy-4-oxo-4H-chromen-2-yl)-2,6-dimethoxyphenyl beta-d-glucopyranoside. Error bars indicate standard error of means.
Fig. 5Metabolic pathways cloud plot for significantly changed metabolites (p < 0.01) in ‘Cortland’ and ‘Red Delicious’ apples during 7 month storage and in relation to scald development as well as in response to DPA and 1-MCP treatments. The radius of each circle represents the number of metabolites relative to the number of metabolites represented by other circles. Darker circles mean more pathways are represented. A corresponding table is also provided as Supplementary data (Supporting data) for the name of the information (Gowda et al., 2014, Tautenhahn et al., 2012).